• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-2329
Device Problem Device Dislodged or Dislocated (2923)
Event Date 03/12/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10:  product id l-evolutfx-2329 (lot: 0012050353); product type: 0195-heart valves; implant date ; explant date section d references the main component of the system.Other medical products in use during the event include: brand name evolut fx valve; product id evolutfx-26 (serial: (b)(6)); product type: 0195-heart valves; implant date (b)(6) 2024; explant date (b)(6) 2024.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the patient had a type 0 bicuspid native valve.Pre-implant balloon aortic valvuloplasty (bav) as performed using an 18mm true balloon over a non-medtronic (lunderquist) guidewire.The valve (b)(6) crossed the annulus and was deployed.Echocardiogram was performed to confirm placement, and the delivery catheter system (dcs) nosecone was attempted to be removed.As the nosecone came through the valve, the valve dislodged.The interventional cardiologist attempted to snare the dislodged valve (b)(6), as a second valve (b)(6) was loaded to attempt implant.However, the patient became unstable prior to attempting second valve implant and cardiopulmonary resuscitation (cpr) was initiated.The second valve (b)(6) was opened but not used, and discarded. the cardiovascular surgeon proceeded to take the patient to the operating room in order to explant the dislodged valve (b)(6) and perform a surgical aortic valve replacement (savr).The surgical valve was successfully implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Updated h.6 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18939447
MDR Text Key338082103
Report Number2025587-2024-01765
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00763000365677
UDI-Public00763000365677
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-EVOLUTFX-2329
Device Catalogue NumberD-EVOLUTFX-2329
Device Lot Number0012084973
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/12/2024
Initial Date FDA Received03/20/2024
Supplement Dates Manufacturer Received05/17/2024
Supplement Dates FDA Received05/24/2024
Date Device Manufactured12/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H11...
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexFemale
-
-